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Target of Rapamycin Complex 1 (TORC1) signaling
promotes growth and aging. Inhibition of TORC1
leads to reduced protein translation, which promotes
longevity. TORC1-dependent post-transcriptional
regulation of protein translation has been well stud-
ied, while analogous transcriptional regulation is
less understood. Here we screen fission yeast mu-
tants for resistance to Torin1, which inhibits TORC1
and cell growth. Cells lacking the GATA factor Gaf1
(gaf1D) grow normally even in high doses of Torin1.
The gaf1D mutation shortens the chronological
lifespan of non-dividing cells and diminishes
Torin1-mediated longevity. Expression profiling and
genome-wide binding experiments show that upon
TORC1 inhibition, Gaf1 directly upregulates genes
for small-molecule metabolic pathways and indi-
rectly represses genes for protein translation.
Surprisingly, Gaf1 binds to and downregulates the
tRNA genes, so it also functions as a transcription
factor for RNA polymerase III. Thus, Gaf1 controls
the transcription of both protein-coding and tRNA
genes to inhibit translation and growth downstream
of TORC1.
INTRODUCTION
The conserved Target of Rapamycin (TOR) signaling pathway is
a key regulator for cellular growth andmetabolism in response to
nutrients and energy (Gonzalez and Rallis, 2017; Gonza´lez and
Hall, 2017; Valvezan and Manning, 2019; Wei et al., 2013). TOR
generally functions via two multi-protein complexes, TORC1
and TORC2, which coordinate distinct aspects of growth and
associated processes (Hartmuth and Petersen, 2009; Ikai3240 Cell Reports 30, 3240–3249, March 10, 2020 ª 2020 The Autho
This is an open access article under the CC BY license (http://creativeet al., 2011). TORC2 is not required for cell proliferation in fission
yeast (Schizosaccharomyces pombe) but is required for sexual
differentiation, stress response, and actin function (Matsuo
et al., 2007; Weisman and Choder, 2001). TORC1 activates
protein synthesis and other anabolic processes and inhibits
autophagy and other catabolic processes. Active TORC1 func-
tions on lysosomes, or vacuoles in yeast, in response to growth
signals (Binda et al., 2009; Chia et al., 2017; Po€us and Codogno,
2011; Valbuena et al., 2012).
In all organisms tested, TORC1 promotes aging and shortens
lifespan (Gonzalez and Rallis, 2017; Gonza´lez and Hall, 2017;
Kaeberlein, 2010;Wei et al., 2013). Lifespan is influenced bymul-
tiple TORC1-dependent processes, including mitochondrial
activity (Hill and Van Remmen, 2014), autophagy (Saxton and
Sabatini, 2017), and protein translation (Bjedov and Partridge,
2011; Rallis et al., 2013). Protein translation is controlled post-
transcriptionally by TORC1 via phosphorylation of ribosomal
S6 kinase (S6K) and the translation factors eIF2a and 4E-BP
(Ma and Blenis, 2009). Inhibition of S6K can extend lifespan in
several organisms (Bjedov et al., 2010; Rallis et al., 2014; Roux
et al., 2006; Selman et al., 2009).
Besides post-transcriptional mechanisms, TORC1 promotes
translational capacity and aging via transcriptional regulation
(Valvezan andManning, 2019). It stimulates transcription of ribo-
somal RNAs via RNA polymerases I and III (RNA Pol I and RNA
Pol III) (Iadevaia et al., 2014), although mechanisms are poorly
understood. TORC1 may regulate RNA Pol I transcription via
general transcription factors (Hannan et al., 2003; Mayer et al.,
2004). TORC1 also regulates the conserved Maf1 factor, which
inhibits RNA Pol III (Cai and Wei, 2015; Graczyk et al., 2018; Mi-
chels et al., 2010; Shor et al., 2010; Wei and Zheng, 2010; Wei
et al., 2009). RNA Pol III transcribes the highly abundant 5S ribo-
somal RNAs and transfer RNAs (tRNAs), which are central for
translation, besides other small RNAs (Arimbasseri and Maraia,
2016). Given the focus on protein-coding gene transcription,
the regulation of RNA Pol III transcription is less well understood.
A recent study shows that RNA Pol III activity limits the lifespanr(s).
commons.org/licenses/by/4.0/).
downstream of TORC1 (Filer et al., 2017). Altogether, these find-
ings suggest that TORC1-mediated control of RNA Pol III
transcription is universally important for translation and aging.
However, no specific transcription factors have been identified
that bind to RNA Pol III-dependent promoters and thus mediate
translational control and lifespan.
The conserved S. pombe GATA transcription factor Gaf1 reg-
ulates responses to nitrogen limitation downstream of TORC1
(Laor et al., 2015). Gaf1 can regulate gene expression either
positively or negatively (Kim et al., 2012). Here we show that
Gaf1 is required for growth suppression upon TORC1 inhibition.
Gaf1 binds not only to the promoters of certain protein-coding
genes but also to the RNA Pol III-transcribed tRNA genes, which
leads to their repression. Mutant cells lacking Gaf1 feature a
shortened chronological lifespan. Our results uncover a
transcription factor downstream of TORC1 that directly inhibits
transcription of the tRNA genes, providing a mechanism for
transcriptional control of global protein translation that prolongs
lifespan.
RESULTS AND DISCUSSION
Genes Required for TOR-Mediated Growth Inhibition
TORC1 and TORC2 can be inhibited by Torin1, an ATP analog
that blocks cell proliferation in S. pombe (Atkin et al., 2014;
Thoreen et al., 2009). Using a low Torin1 dose (5 mM),
S. pombemutants have been screened for resistance and sensi-
tivity to reduced TOR signaling (Lie et al., 2018). Here we
screened mutants under a four-fold higher Torin1 dose
(20 mM). This dose blocked cell growth (Figure 1A) and reduced
the size of both cells and vacuoles (Figure 1B). Global protein
translation was also reduced by Torin1, as reflected by reduced
phosphorylation of ribosomal S6 protein and increased total and
phosphorylated eIF2a (Figure 1C). Altogether, these phenotypes
look like those triggered by caffeine and rapamycin that block
TORC1 function (Rallis et al., 2013). We conclude that Torin1
leads to phenotypes that are diagnostic for TORC1 inhibition.
We screened for deletion mutants that can suppress the
strong growth inhibition by 20 mM Torin1 (Figure 1D). Overall,
19 mutants were resistant to Torin1-mediated growth inhibition
in all 4 repeats (Figure 1E; Table S1), 9 of which were identified
in the previous screen (Lie et al., 2018). We independently vali-
dated these 19 mutants, both by PCR and by backcrossing to
a wild-type strain. The backcrossed mutants were spotted on
Torin1 plates to confirm linkage of the drug-resistant phenotype
to the deletion cassette. Although wild-type cells did not grow in
Torin1, all 19 mutants managed to grow to various extents in
different concentrations of Torin1 (Figure 1F). Four mutants
were resistant to Torin1 at all concentrations, showing similar
growth as on untreated medium (Figure 1F, red frames).
Some mutants feature resistance to multiple rather than spe-
cific drugs (Dawson et al., 2008). To exclude this possibility for
the Torin1-resistant mutants, we assayed their growth in four
other drugs; this analysis showed that all mutants were at least
as sensitive to the other drugs as the wild-type control (Fig-
ure S1A), indicating that their Torin1 resistance does not reflect
multi-drug resistance. To exclude the possibility that resistance
simply reflects that mutants cannot take up Torin1, we testedwhether the Torin1-resistant mutants still showed other pheno-
types of TORC1 inhibition (Figures 1B and 1C). The mutants still
showed reduced ribosomal S6 protein phosphorylation after
Torin1 treatment, except aca1D (Figure S1B), and decreased
cell size (Figure S1C). These results indicate that Torin1 is taken
up by the mutant cells, which differ in sensitivity to different
TORC1 functions. Moreover, in all but the aca1D mutant, the
growth resistance to Torin1 may be independent of translational
control by ribosomal S6 phosphorylation.
The 19 genes identified in our screen function in limited cellular
processes (Figure 1G; Table S1). Vesicular transport and vacu-
olar functions were associated with 13 genes, 6 of which encode
components of endosomal sorting complexes required for trans-
port (ESCRT). Many of these proteins are part of the Nbr1-medi-
ated vacuolar targeting (NVT) autophagic system (Liu et al.,
2015). The NVT pathway does not contain core Atg proteins
but depends on ESCRTs and the multi-vesicular body to deliver
soluble cargoes to the vacuole. How might vesicular transport
and the NVT pathway relate to TOR signaling? Disruption of
vesicle-mediated transport at the endosome triggers a meta-
bolic signature similar to TORC1 inhibition (Mulleder et al.,
2016). It is possible that TORC1 controls the NVT pathway or
that some of our mutants affect TORC1 localization to the vacu-
ole, thus rendering the system resistant to Torin1 inhibition. A
gene from the screen encodes the GATA transcription factor
Gaf1. In budding yeast, components of Golgi-to-vacuole traf-
ficking are required for TORC1-responsive regulation of GATA
factors (Fayyadkazan et al., 2014; Puria et al., 2008). Given our
interest in TORC1-dependent gene regulation and the strong
Torin1-resistance of gaf1D mutants (Figure 1G), we further
analyzed the function of Gaf1.
Gaf1 Is Required for Normal Lifespan and Lifespan
Extension by Torin1 Treatment
TORC1 inhibition through nutrient limitation or rapamycin pro-
longs chronological lifespan in S. pombe (Rallis et al., 2013,
2014), defined as the time post-mitotic cells remain viable in sta-
tionary phase. Given that Gaf1 is required to arrest growth upon
TOR inhibition, we hypothesized that Gaf1 may also play a role
in chronological lifespan. Indeed, gaf1D cells were shorter lived,
with median and maximum lifespans of 3 and 16 days, respec-
tively, compared with 5 and 20 days for wild-type cells (Figure 2).
Thus, Gaf1 is required for the normal lifespan of non-dividing cells.
Torin1 increases lifespan in flies (Mason et al., 2018) and sup-
presses senescence in human tissue cultures (Leontieva and
Blagosklonny, 2016). To analyze the effect of Torin1 on chrono-
logical lifespan in S. pombe, and any role of Gaf1 in this condi-
tion, we pre-treated exponentially growing wild-type and gaf1D
cells with Torin1 and tested for subsequent effects on lifespan
during the stationary phase. Torin1 substantially prolonged life-
span in wild-type cells, with median and maximum lifespans of
18 and 33 days, respectively, compared with 5 and 20 days in
untreated cells (Figure 2A). In gaf1D cells, Torin1 also prolonged
lifespan but to a lesser extent than in wild-type cells, with median
and maximum lifespans of 13 and 30 days, respectively (Fig-
ure 2A). To quantify the role of Gaf1 in Torin1-mediated longevity,
we calculated the areas under the curve (AUCs, measured
as days 3 percentage of survival from lifespan assays). InCell Reports 30, 3240–3249, March 10, 2020 3241
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Figure 1. Screen for Torin1-Resistant Mutants
(A) Torin1 blocks cell proliferation. Top: ten-fold serial dilutions of wild-type (WT) cells spotted on rich solid medium. Bottom: growth profiles in rich liquid medium
using a microfermentor, in the absence (control) and presence of Torin1.
(B) Torin1 leads to decreased cell and vacuole sizes. Sizes of septated WT cells (top) and vacuoles (bottom) during Torin1 treatment.
(C) Torin1 alters phosphorylation status of translational regulators. Phosphorylated (P) and total amounts (T) of ribosomal S6 and eIF2a proteins in WT cells
following Torin1 treatment in rich (YES) or minimal (EMM2) media.
(D) Design of genome-wide screens to identify mutants resistant to Torin1-mediated growth inhibition. We screened Bioneer version 2 (3,005 mutants) and
Bioneer version 5 (3,420 mutants) of deletion libraries (Kim et al., 2010) in two independent repeats each, using 20 mM Torin1 on rich solid medium (YES).
(E) Example of deletion library plate with Torin1, containing 1,536 colonies with each mutant printed in quadruplicate. Red boxes indicate three Torin1-resistant
mutants.
(F) Torin1 sensitivity test using spotting assays for a WT control and the 19 resistant mutants identified, using different Torin1 concentrations as indicated.
Red frames: 4 mutants showing strong resistance to all Torin1 concentrations tested.
(G) Cellular processes associated with the 19 genes (red) required for Torin1-mediated growth inhibition.
See also Figure S1 and Table S1.wild-type cells, the lifespan was prolonged from an average AUC
of 1,044 to 2,689 (increase of 1,645), whereas in gaf1D cells, the
lifespan was prolonged to a lesser extent, from an average AUC
of 681 to 1,709 (increase of 1,027) (Figure 2B). We conclude that
Gaf1 is also required for the full lifespan extension resulting from
Torin1-mediated TOR inhibition during cell proliferation. Howev-
er, Torin1 still can prolong lifespan considerably without Gaf1,
indicating that other factors contribute to this longevity. Indeed,3242 Cell Reports 30, 3240–3249, March 10, 2020we have identified several proteins required for lifespan exten-
sion when TORC1 is inhibited, including the S6K protein Sck2
(Rallis et al., 2014).
Gaf1-Dependent Transcriptome Regulation following
TOR Inhibition
Given that Gaf1was essential for growth inhibition by Torin1 (Fig-
ure 1G), we further analyzed its function in this condition. Gaf1
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Figure 2. Gaf1 Is Required for Longevity
(A) Chronological lifespan assays in WT and gaf1D cells grown in EMM2 in the absence or presence of 8 mMTorin1. Error bars represent SDs from 3 independent
cell cultures, each measured 3 times per time point.
(B) AUC for lifespan assays of WT and gaf1Dmutant cells without or with Torin1 treatment. Vertical bars: Torin1-mediated increase in average AUC values for WT
(black) and gaf1D (red), with the p value reflecting the significantly larger lifespan increase in WT than in gaf1D cells.accumulated in the nucleus within a few minutes following treat-
ment with Torin1 (Figure 3A) or with caffeine and rapamycin (Fig-
ure S2), drugs that inhibit TORC1, but not TORC2 (Rallis et al.,
2013). Consistently, Gaf1 is known to translocate to the nucleus
during nitrogen limitation, which also inhibits TORC1, and
biochemical analyses have shown that Gaf1 localization and
phosphorylation depend on TORC1 activity (Laor et al., 2015;
Ma et al., 2015). This regulation of GATA transcription factors
is conserved: budding yeast Gln3 and Gat1 (Broach, 2012) and
mammalian GATA6 (Xie et al., 2015) are also sequestered in
the cytoplasm by active TORC1 and translocate to the nucleus
upon TORC1 inhibition.
In S. pombe, Gaf1 activates genes functioning in amino-acid
transport but represses ste11, encoding a master regulator for
meioticdifferentiation (Kimetal., 2012;Maetal., 2015). Tosystem-
atically identify Gaf1-dependent transcripts, we performedmicro-
array analyses of wild-type and gaf1D cells, both before and after
Torin1 treatment. Before Torin1 treatment, wild-type and gaf1D
cells showed similar expression signatures (Figures 3B and 3C).
Weconclude that inproliferating cells,Gaf1playsnooranegligible
role in gene regulation, consistent with its cytoplasmic localization
when TORC1 is active (Figure 3A; Laor et al., 2015).
However, Torin1 treatment resulted in substantial transcrip-
tome changes in both wild-type and gaf1D cells, but in gaf1D
cells, the expression signature markedly differed from the signa-
ture in wild-type cells (Figures 3B and 3C). Overall, 90 and 108
genes consistently showed R1.5-fold higher or lower expres-
sion, respectively, in gaf1D relative to wild-type cells after Torin1
treatment (Figure 3B; Table S2). Cells treated with caffeine and
rapamycin, which inhibit TORC1, but not TORC2 (Rallis et al.,
2013), showed similar expression signatures as Torin1-treated
cells in both wild-type and gaf1D cells (Figures 3B and 3C).
This result indicates that the Torin1-mediated expression signa-
tures in wild-type and gaf1D cells reflect TORC1 inhibition. We
conclude that after TORC1 inhibition, Gaf1 affects the expres-
sion of 200 genes, either positively or negatively.
We performed functional enrichment analyses for these Gaf1-
dependent genes using AnGeLi and g:profiler (Bitton et al., 2015;Raudvere et al., 2019). The 90 genes that were expressed higher
in gaf1D than in wild-type cells (i.e., genes repressed by Gaf1)
were typically downregulated in Torin1-treated wild-type cells
but less so in gaf1D cells (Figure 3B). These genes were enriched
in anabolic processes such as biosynthesis (61 genes, p = 9.43
1010), ribosome biogenesis (19 genes, p = 1.6 3 103), and
cytoplasmic translation (31 genes, p = 1.0 3 1016), including
25 genes encoding ribosomal proteins. In budding yeast and
worms, genetic inhibition of ribosomal proteins leads to lifespan
extension (Hansen et al., 2008; McCormick et al., 2015). Fig-
ure S3 visualizes all Gene Ontology (GO) biological processes
enriched among the 90 genes. Many of these genes are also
repressed as part of the core environmental stress response
(43 genes, p = 1.4 3 1020; Chen et al., 2003) and are highly ex-
pressed in proliferating cells (mean of 46.9 mRNA copies/cell
versus 7.5 copies for all mRNAs, p = 1.2 3 1026; Marguerat
et al., 2012). We conclude that upon TORC1 inhibition, Gaf1 con-
tributes to the downregulation of highly expressed genes
functioning in protein synthesis.
The 108 genes that were expressed lower in gaf1D than in
wild-type cells (i.e., genes induced by Gaf1) were typically upre-
gulated in Torin1-treated wild-type cells but less so in gaf1D cells
(Figure 3B). These genes were enriched in several metabolic pro-
cesses of small molecules, including organonitrogen com-
pounds (43 genes, p = 4.6 3 1014), amino acids (18 genes,
p = 4.13 105), urea (6 genes, p = 7.33 105), and organic acids
(20 genes, p = 0.001) (Figure S3). There was also a substantial
overlap with genes that are induced by nitrogen limitation (43
genes, p = 1.3 3 1029; Mata et al., 2002) and genes that are
periodically expressed during the cell cycle (41 genes, p =
1.6 3 1012; Marguerat et al., 2006), including 9 histone genes.
These results suggest a Gaf1-dependent transcriptional pro-
gram to adjust the metabolism of amino acids and other mole-
cules, possibly to recycle nutrients under conditions that do
not allow rapid proliferation. Similar gene-expression changes
are mediated by budding yeast Gln3 and Gat1 under conditions
of TORC1 inhibition (Kuroda et al., 2019; Scherens et al., 2006).
Altogether, these findings indicate that Gaf1 regulatesCell Reports 30, 3240–3249, March 10, 2020 3243
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(A) Top panels: fluorescence microscopy of cells
expressing GFP-tagged Gaf1 (left) with chromatin
stained by Hoechst 33342 (middle) after 10 min of
exposure to 20 mM Torin1. Bottom panels: fluores-
cence microscopy of live Gaf1-GFP cells, showing
stack projections of 1-min time lapses in rich
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intervals after addition of either DMSO (solvent
control; upper panels) or Torin1 (20 mM final; lower
panels). Gaf1-GFP is visible inside the nucleuswithin
3 min after Torin1 addition. Scale bars: 5 mm. See
also Figure S2.
(B) Hierarchical clustering of microarray data. Col-
umns represent WT or gaf1 mutants (gaf1D) before
(untreated) and after 1 h of treatment with 20 mM
Torin1 or with 10 mM caffeine and 100 ng/mL of ra-
pamycin (Caff+Rap). Rows represent the 198 genes
whose mRNA levels changed R1.5-fold in Torin1-
treated gaf1D cells relative toWT cells, consisting of
90 genes showing higher expression (red bar) and
108 genes showing lower expression (blue bar) in
gaf1D cells. In untreated cells, only 3 genes showed
R1.5-fold expression changes in gaf1D relative to
WT cells. Average RNA expression changes (from 2
independent repeats) in the different genetic and
pharmacological conditions relative to WT control
cells are color coded as shown. The orange bars
indicate 43 genes whose promoters were bound by
Gaf1 after 60 min with Torin1. See also Figure S3.
(C) Principal-component (PC) analysis of all genes
measured by microarrays. PC1 separates untreated
cells fromcells treatedwith Torin1 (T) or caffeine and
rapamycin (CT), while PC2 separatesWT (blue) from
gaf1mutants (gaf1D, red). Percentagesof the xandy
axes show the contribution of the corresponding PC
to the difference in the data.physiological changes supporting the growth arrest triggered by
TORC1 inhibition.
Gaf1 Binds to Both Coding and tRNA Genes following
TOR Inhibition
The microarray analyses identified genes whose expression
depends on Gaf1, some of which may be directly regulated
by Gaf1. To detect gene promoters bound by Gaf1, we per-
formed chromatin immunoprecipitation sequencing (ChIP-
seq) of Gaf1-GFP cells. The number of Gaf1-bound promoters
increased from 165 before Torin1 treatment to 454 after
Torin1 treatment, with 93 genes in common between the
two conditions (Figure 4A). Gaf1 binding sites upstream of
close, divergently expressed genes were assigned to both
genes. The Gaf1 target genes after Torin1 treatment con-
sisted of 245 protein-coding genes and 209 non-coding genes
(Table S3).
The protein-coding Gaf1 target genes were significantly en-
riched in metabolic processes of organonitrogen compounds
(55 genes, p = 1.4 3 106), including nucleotides (24 genes,
p = 0.0009) and organic acids (34 genes, p = 0.0003) (Figure S4).
They were also enriched for genes induced by nitrogen limitation
(40 genes, p = 1.63 1011) and periodically expressed during the
cell cycle (53 genes, p = 4.53 106). Overall, these target genes3244 Cell Reports 30, 3240–3249, March 10, 2020showed similar functional enrichments to the genes whose
expression was induced by Gaf1. Accordingly, Gaf1 binding
sites were enriched among the genes induced by Gaf1 (Fig-
ure 3B, orange bars). Moreover, most protein-coding genes
bound by Gaf1 were induced by TORC1 inhibition but less so
in gaf1D cells, leading to distinct clusters for wild-type and
mutant conditions (Figure 4B). We conclude that coding Gaf1
target genes are mostly upregulated by Gaf1 when TORC1 is
inhibited.
Notably, Gaf1 bound to the promoters of 20 transcription fac-
tor genes (Table S3; Figure S4). Typically, these factors were
induced in wild-type cells after TORC1 inhibition but less so in
gaf1D cells. Many of these factors are involved in stress re-
sponses or cell-cycle regulation, including Atf1 (Wilkinson
et al., 1996), Cbf12 (Chen et al., 2003), Fep1 (Bekker et al.,
1991), Fil1 (Duncan et al., 2018), Hsr1 (Chen et al., 2008), Klf1
(Shimanuki et al., 2013), Loz1 (Corkins et al., 2013), Pap1
(Chen et al., 2008), Php3 (Mercier et al., 2006), and Sep1 (Rustici
et al., 2004). These transcription-factor targets indicate that Gaf1
may indirectly control some Gaf1-dependent genes via other
transcription factors. Gaf1 inhibited the expression of many
genes functioning in translation (Figure S3), but these genes
were not among its direct binding targets. These genes may
thus be indirectly regulated by Gaf1; for example, Atf1 represses
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Figure 4. Gaf1 Regulation of Protein-Coding and tRNA Genes
(A) Gaf1 binding sites across the 3 S. pombe chromosomes, before (0 min,
blue) and after (60 min, orange) treatment with 20 mM Torin1. See also Fig-
ure S4.
(B) Hierarchical clustering of microarray data for 150 protein-coding genes
bound by Gaf1 after Torin1 treatment and for which expression data were
available for all conditions. The conditions have been clustered aswell (red tree
on top) and are grouped as follows: untreatedWT and gaf1D cells (Uwt, Ugaf1),
caffeine+rapamycin- or Torin1-treated gaf1D cells (CRgaf1, Tgaf1), and caf-
feine+rapamycin- or Torin1-treatedWT cells (CRwt, Twt). Expression changes
are color coded as in Figure 3B.
(C) Gaf1 shows increased binding to tRNA genes after Torin1 treatment. Top,
red curves: average Gaf1 binding profiles aligned to transcription start sites
(TSSs) of all S. pombe tRNA genes before (0 min) and after (60 min) Torin1translation-related genes during stress (Chen et al., 2008),
raising the possibility that it also represses these genes during
TORC1 inhibition in a Gaf1-dependent manner.
The 209 non-coding genes among the Gaf1 targets included
82 tRNA genes and a small nucleolar RNA (snoRNA) involved
in tRNA regulation, besides large non-coding RNAs (Table S3).
Coverage plotting indicated that Gaf1 binds to all tRNA genes
that are clustered in S. pombe (Figure 4C; Figure S5). Binding
occurred near the transcription start sites for tRNA genes and
strongly increased after Torin1 treatment (Figure 4C). We
conclude that Gaf1 binds not only to genes transcribed by
RNA Pol II but also to the tRNA genes transcribed by RNA Pol
III. To address whether Gaf1 represses or activates tRNAs, we
performed northern analyses of tRNA gene expression as a func-
tion of Gaf1 and Torin1. The abundant mature tRNAs are rapidly
processed from precursor tRNAs, which need to be assayed to
detect expression changes (Otsubo et al., 2018). The expression
of tRNA precursors decreased during Torin1 treatment in wild-
type cells, while in gaf1D cells their expression was higher and
showed a delayed and less pronounced decrease, especially
at later time points (Figures 4D and 4E). We conclude that Gaf1
binds to tRNA genes and inhibits their expression upon TOR
inhibition.
Downregulation of precursor tRNA expression is required
for TORC1 inhibition in S. pombe (Otsubo et al., 2018), indi-
cating that tRNAs can act upstream of TORC1. Our experi-
ments, conversely, point to a mechanism of tRNA regulation
downstream of TORC1. Altogether, these findings suggest
regulatory feedback, involving precursor tRNAs, TORC1, and
Gaf1, to match tRNA expression to physiological require-
ments. Our results reveal a transcription factor that not only
controls RNA Pol II-mediated expression of genes functioning
in translation- and metabolism-related processes but also
globally inhibits RNA Pol III-mediated expression of tRNAs.
It will be interesting to test whether the latter function is
conserved for orthologous GATA transcription factors.
Studies of Gln3 and Gat1 function in budding yeast have
excluded tRNAs and are therefore not conclusive with respect
to tRNA gene regulation (Kuroda et al., 2019; Scherens et al.,
2006).treatment, along with corresponding control ChIP-seq data (hemagglutinin
[HA]). Bottom: heatmaps of Gaf1 binding around the TSS of all 196 tRNAs,
ordered by normalized ChIP-seq coverage. See also Figure S5.
(D) Northern blots of precursor tRNAs for leucine (top) and asparagine (middle)
fromWT and gaf1D cells, treated with 20 mMTorin1 over 120 min as indicated.
Probes to detect precursor tRNAs, indicated with red bars, are as described
before (Otsubo et al., 2018). Probes for cdc2 were used as loading control
(bottom).
(E) Northern quantitation of leucine and asparagine precursor tRNAs relative to
WT time 0 and normalized to loading controls (three independent repeats
shown as dots). Asterisks denote significant differences in pre-tRNA levels
between WT and gaf1D cells from same time point (t test, p < 0.05).
(F) Model for Gaf1-mediated transcriptional repression of translation down-
stream of TORC1. Following TORC1 inhibition, Gaf1 activates the transcription
of genes for small-molecule metabolic pathways and represses the tran-
scription of tRNAs and other genes functioning in translation (the latter via
indirect control, hatched). Together with the S6K-mediated translational
control (Ma and Blenis, 2009), this transcriptional branch contributes to
longevity.
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Conclusions
The GATA transcription factor Gaf1 is essential for blocking cell
proliferation with Torin1; in its absence, cell growth remains
normal, even in high doses of Torin1 (Figure 1G). Gaf1 is also
required for normal chronological lifespan and contributes to,
but is not necessary for, the longevity of Torin1-treated cells (Fig-
ure 2). Upon TORC1 inhibition, Gaf1 inhibits the expression of
genes functioning in protein translation, including protein-coding
genes, which may be indirectly controlled by Gaf1, and tRNA
genes, which are binding targets of Gaf1 (Figures 3 and 4).
Gaf1 also positively controls genes functioning in metabolic
pathways for nitrogen-containing molecules, which support the
adaptation to lowered protein synthesis. Thus, Gaf1 can directly
regulate both RNA Pol II- and RNA Pol III-transcribed genes. It is
possible that Gaf1 elicits its repressor activity at tRNA genes by
recruiting a histone deacetylase: work in S. pombe has identified
potential loading sites for Clr6 complex components at tRNAs
(Zilio et al., 2014). Downregulation of global protein translation
is beneficial for longevity in all organisms studied, including
S. pombe (Kaeberlein and Kennedy, 2011; Rallis and Ba¨hler,
2013). Given its role in repressing diverse translation-related fac-
tors, Gaf1 may inhibit aging by contributing to the downregula-
tion of translation upon TORC1 inhibition (Figure 4F). Gaf1 thus
defines a transcription-based branch of translational and meta-
bolic control downstream of TORC1, in parallel to the post-trans-
lational branch exerted by translational regulators like S6K (Fig-
ure 4F). This transcriptional branch is essential for growth
inhibition triggered by lowered TORC1 activity.
RepressionofRNAPol III prolongs lifespan in yeast,worms, and
flies and is required for the lifespan extensionmediated by TORC1
inhibition (Filer et al., 2017). Besides general transcription factors
such as TFIIIB, TFIIIC, and TBP, several factors control RNA Pol III
transcription without directly binding to DNA (Hummel et al.,
2019), including the RNA Pol III inhibitor Maf1, the coactivator
PNRC, and MYC, which interacts with the RNA Pol III basal appa-
ratus (Campbell andWhite, 2014; Graczyk et al., 2018; Zhou et al.,
2007). To our knowledge, the TORC1 target Gaf1 is the first spe-
cific transcription factor shown to globally bind to and repress the
tRNA genes. Thus, Gaf1 could exert the aging-associated func-
tion of RNAPol III. Recentwork in flies shows thatGATA transcrip-
tion factors can mediate the effects of dietary restriction on life-
span (Dobson et al., 2018). This finding raises the possibility that
Gaf1 regulation of aging-related processes is conserved and
that other GATA factors exert similar functions downstream of
TORC1. The mouse and human ortholog of Gaf1, GATA6, is
involved in differentiation, stem cell maintenance, and cancer
(Viger et al., 2008; Wamaitha et al., 2015; Zhong et al., 2011). It
is plausible that GATA6 exerts these important functions by regu-
lating translation-related genes, including tRNAs.STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Phospho-(Ser/Thr) Akt Substrate (PAS) Cell Signaling Cat#9611; RRID:AB_330302
Anti-rps6 Abcam Cat#ab40820; RRID:AB_945319
anti-rabbit HRP Abcam Cat#ab6721; RRID:AB_955447
Anti-GFP Abcam Cat#ab290; RRID:AB_303395
Anti-HA Abcam Cat#ab9110; RRID:AB_307019
Dynabeads M-280 sheep
anti Rabbit IgG
Thermo Fisher Cat# 11203D; RRID:AB_2783009
Chemicals, Peptides, and Recombinant Proteins
Rapamycin LC Laboratories # R-5000
Caffeine Sigma # 27602-250G
Torin1 TOCRIS #4247
FM4-64 ThermoFisher #T13320
Calcuofluor Sigma #18909
Doxycycline hyclate Sigma # D9891
CdSO4 Sigma # 202924
Cycloheximide Sigma # C7698
PMSF Sigma #10837091001
Phosphatase Inhibitor Cocktail 1 Sigma #P2850
Phosphatase Inhibitor Cocktail 2 Sigma #P5726
Complete, EDTA free protease
Inhibitor Cocktail
Merck #11873580001
Critical Commercial Assays
Microarrays Agilent Custom design 8x15K
NEBNext ultra DNA Library Prep kit New England Biolabs E7370L
ECL Western Blotting Detection System GE Healthcare GERPN2134
DIG Oligonucleotide 30 End Labeling Kit,
2nd generation
Merk #03353575910
DIG Luminescent Detection Kit Merk # 11363514910
DIG Wash and Block Buffer Set Merk # 11585762001
BrightStar-Plus Positively Charged
Nylon Membrane
Thermo Fisher # AM10100
Mini-PROTEAN TBE-Urea Precast Gels Bio Rad # 4566036
MiSeq Reagent Kit v3 (150-cycle) Illumina MS-102-3001
Deposited Data
ChIP-seq data ENA Accession numbers:
PRJEB32910 and ERP115647
Microarray data ArrayExpress Accession number: E-MTAB-8569
Experimental Models: Organisms/Strains
Fission yeast 972- Bahler lab strainlist JB903
Fission yeast Gaf1-GFP Bahler lab strainlist JB1744
Fission yeast Bioneer strains Bioneer N/A
Oligonucleotides
Cdc-SRT cdc2-SRT GGGCAGGGTCATAAACAAGC Cle´ment-Ziza et al., 2014
tRNA-leu-CAA-intron-5 GACTATCGTCCAAGTATTACTTGAGTGCTGCG Otsubo et al., 2018
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
tRNA-asn01-5leader TATGCTACCCGACCTATAATGCTCCTGGTGAG Otsubo et al., 2018
Software and Algorithms
ImageJ Schneider et al., 2012 https://imagej.nih.gov/ij/
Volocity acquisition program PerkinElmer https://www.perkinelmer.com/
Volocity quantitation package PerkinElmer https://www.perkinelmer.com/
GEM Guo et al., 2012 http://groups.csail.mit.edu/cgs/gem/
Bowtie2 Langmead and Salzberg, 2012 http://bowtie-bio.sourceforge.net/
bowtie2/index.shtml
ChIPpeakAnno Zhu et al., 2010 https://www.bioconductor.org/packages/
release/bioc/html/ChIPpeakAnno.html
Deeptools Ramı´rez et al., 2016 https://deeptools.readthedocs.io/en/develop/
Samtools Li et al., 2009 http://samtools.sourceforge.net/LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, J€urg
Ba¨hler (j.bahler@ucl.ac.uk). This study generated new S. pombe strains that are available from the Lead Contact without restriction
upon request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
This study has been conducted using S. pombe as experimental model. For wild-type control strains, we used 972 h- or the parental
strains for the deletion library, ED666 (h+ ade6-M210 ura4-D18 leu1–32) and ED668 (h+ ade6- M216 ura4-D18 leu1–32). The Bioneer
haploid deletion library strains used for further studies were PCR-validated and backcrossed with 972 h-. The gaf1-GFP strain was
generated as described (Bahler et al., 1998). Cell cultures were grown in yeast extract plus supplements (YES) as default or in
Edinburgh minimal medium (EMM2) if indicated (Moreno et al., 1991). Liquid cultures were grown at 32C with shaking at 130
rotations per minute.
METHOD DETAILS
Drug sensitivity assays
Cells were grown in liquid YES to an OD600 of 0.5. Ten-fold serial dilutions of cells were spotted onto YES agar plates, using replica
platers for 48-well or 96-well plates (Sigma), with or without drugs as indicated in figure legends.
Measurement of cell size and fluorescence microscopy
To determine cell size, control and drug-treated cells were fixed in 4% formaldehyde for 10 min at room temperature, washed with
50 mM sodium citrate, 100mM sodium phosphate, and stained with Calcofluor (50 mg/ml). Microscopy was performed using a DAPI
filter for Calcofluor detection and a Hamamatsu ORCA-ER C4742-95 digital camera fitted to a Zeiss Axioskop microscope with EC
plan-NEOFLUAR 63x 1.25 NA oil objective. Images were recorded using the Volocity acquisition program (PerkinElmer). At least 100
septated cells were counted and analyzed for each condition using the Volocity quantitation package (PerkinElmer). Results were
analyzed in R. For fluorescence microscopy of Gaf1-GFP cells, we used a spinning disk confocal microscope (Yokogawa
CSU-X1 head mounted on Olympus body; CoolSnap HQ2 camera [Roper Scientific], Plan Apochromat 100X, 1.4 NA objective
[Olympus]). The images correspond to maximum intensity projections of 15 image stacks with a Z-step of 0.3 microns. Cells were
immobilized with soybean lectin (Sigma L1395) in two different compartments of a glass-bottom 15 m-Slide 8 well (Ibidi 80821) to
add either DMSO as a solvent control or Torin1 (to a final concentration of 20 mM, dissolved in DMSO). In vivo chromatin staining
was done with Hoechst 33342 (1 mg/ml). As this dye performs poorly in YES, cells were immobilized onto glass bottom wells and
washed three times with liquid EMM2 containing Hoechst 33342 (Sigma-Aldrich B2261) at 1 mg/ml plus Torin1 (20 mM). Cells
were covered with this media and imaged 10 min later. Image analysis and editing was performed using Fiji (ImageJ) open software
(Schindelin et al., 2012).
Measurement of vacuolar size
Vacuolar labeling was performed as described (Codlin and Mole, 2009). Briefly, FM4-64 dye (Molecular Probes) was dissolved in
DMSO at a concentration of 0.82 mM, and 2 mL FM4-64 stock was added to 1 mL log-phase cells with or without drugs. FollowingCell Reports 30, 3240–3249.e1–e4, March 10, 2020 e2
30 min exposure to FM4-64, cells were washed and chased for 40 min in fresh media to allow all dye to reach the vacuole. Fluores-
cence microscopy was performed using a Rhodamine filter for detection of FM4-64 and a Hamamatsu ORCA-ER C4742-95 digital
camera fitted to a Zeiss Axioskop microscope with EC plan-NEOFLUAR 3 63 1.25 NA oil objective. Images were recorded using
the Volocity acquisition program (PerkinElmer). At least 500 vacuoles were measured using the Volocity quantitation package
(PerkinElmer). Results were analyzed in R.
Chronological lifespan assay
Cells were grown in EMM2media as described (Rallis et al., 2013). When cultures reached a stable maximal density, cells were left an
additional 24 hr and then harvested, serially diluted, and incubated on YES plates. The measurement of colony-forming units (CFUs)
was taken at the beginning of the lifespan curve (time point 0: 100%cell survival). CFUmeasurements were conducted on successive
days until cultures dropped to 0.1% cell survival. Error bars represent standard deviation calculated from three independent cultures,
with each culture measured three times at each time point. To determine the chronological lifespan when TOR is inhibited, 8 mM
Torin1 was added to rapidly proliferating cell cultures at OD600 = 0.5 which were then grown to stationary phase, and lifespan
was recorded as described above. AUCs were measured with ImageJ (Schindelin et al., 2012) for all experimental repeats using
lifespans curves on the linear scale for % survival.
High-throughput genetic screening
The haploid deletion libraries were plated onto YES plates containing 100 mg/ml G418 using a RoToR HDA robot (Singer). Multiple
replicate copies of the library were thus generated. Using the RoToR, the libraries were compacted into nine 384-density plates
of plates and then printed onto plates containing 20 mM Torin1. The plates were incubated at 32C for 2 days and then manually
scored for resistant colonies.
Growth assay
Growth in the presence or absence of Torin1 were automatically determined in 48-well flowerplates at 1.5mL volumes, 1000 rpm and
32C using the Biolector microfermentation system (m2p-biolabs). Growth dynamics were modeled using the grofit R package
(Kahm et al., 2010). In the resulting growth curves, the units of the x axis are time (hr) while the y axis shows biomass (arbitrary units)
normalized to biomass at time 0.
Western blotting and antibodies
For protein preparations, cells were diluted in 6 mM Na2HPO4, 4mM NaH2PO4.H2O, 1% Nonidet P-40, 150 mM NaCl, 2 mM EDTA,
50 mM NaF supplemented with protease (PMSF) and phosphatase inhibitors (Sigma cocktails 1 and 2), together with glass beads.
Cells were lysed in a Fastprep-24 machine (MP Biomedicals). Phospho-(Ser/Thr) Akt Substrate (PAS) Antibody (9611, Cell Signaling)
for detection of P-S6 (p27) and anti-rps6 (ab40820, Abcam) were used at 1/2000 dilution. For detection, we used the anti-rabbit HRP-
conjugated antibody (1/5000 dilutions) with the ECL Western Blotting Detection System (GE Healthcare) according to the manufac-
turer’s protocol.
Microarrays
Microarray analysis was performed as previously described (Rallis et al., 2013). Cells were grown in YES to OD600 = 0.5 and har-
vested. Torin1 treatments were done for 1 hr at a concentration of 20 mM. Caffeine/rapamycin treatments were also performed for
1 hr at concentrations 10mM caffeine and 100ng/ml rapamycin. Two independent biological repeats with a dye swap were per-
formed. For each repeat, a corresponding pool of Torin1 or caffeine/rapamycin treated and untreated wild-type and gaf1D cells
was used as a common reference for microarray hybridization. Agilent 8 3 15K custom-made S. pombe expression microarrays
were used, with hybridizations and subsequent washes performed according to the manufacturer’s protocols. The microarrays
were scanned and extracted using GenePix (Molecular Devices), processed using R scripts for quality control and normalization,
and analyzed using GeneSpring GX3 (Agilent). We determined genes that were 1.5-fold upregulated or downregulated in both
repeats of Torin1-treated and caffeine/rapamycin-treated gaf1D cells relative to Torin1-treated and caffeine/rapamycin-treated
wild-type cells respectively.
ChIP-seq
Cells were grown in YES to an OD600 of 0.4. Untreated and Torin 1-treated (20 mM for 15 min or 1 hr) cells were fixed in 1% form-
aldehyde for 30 min and then quenched 10 min with 125mM glycine. Pellets were washed with ice-cold PBS, snap frozen in liquid
nitrogen and stored at 80C. Cell pellets were resuspended in lysis buffer (50 mM HEPES pH 7.6, 1mM EDTA pH 8, 150 mM NaCl,
1% Triton X-100, 0.1% sodium doxycolate, 1mM PMSF and protease inhibitors). Chromatin was obtained following cell disruption
using a Fastprep-24 (MP Biomedicals) and sheared using a Bioruptor (Diagenode). Dynabeads M-280 sheep anti-rabbit IgG were
incubated in lysis buffer and 0.5% BSA for 2 hr with either rabbit anti-GFP (Abcam) for query IPs or 5 ml of rabbit-anti HA (Abcam)
for control IPs. Then, 2 mg of Chromatin extract were inmunoprecipitated for 16 hr using the corresponding antibody-incubated
Dynabeads. Following the washes, DNA was eluted, treated with RNase and proteinase K, and purified using the QIAGEN PCR
MiniElute kit. Sequencing libraries were prepared using the NEBNext ultra DNA Library Prep kit for Illumina (E7370L). DNAe3 Cell Reports 30, 3240–3249.e1–e4, March 10, 2020
was sequenced using IlluminaMi-seqwith a V3 kit, sequencing 75 bp on each end. Sequenceswere aligned to theS. pombe genome
build ASM294v2 using Bowtie2. Peak calling was done with GEM (Guo et al., 2012) (setting–k_min 4 and–k_max 18), and peak
annotation was done with the R package ChIPpeakAnno (Zhu et al., 2010). Peaks were annotated to the closest TSS; for peaks lying
within 500 bp of 2 divergently expressed genes, peaks were annotated to both genes. Normalizations for the plots were performed
using deeptools (Ramı´rez et al., 2016) (normalizing to RPGC and using the parameters –centerReads –binsize 10 –smoothLength 2).
Further analyses were carried out with R scripts (http://www.r-project.org/). Gene enrichment analysis was performed using AnGeLi
(Bitton et al., 2015) and g:profiler (Raudvere et al., 2019).
Northern analyses
Detection of tRNA precursors was performed as described (Otsubo et al., 2018) using Digoxigenin labeled probes (Roche), following
the manufacturer’s instructions. As a loading control, northerns were stripped by incubating for 60 min at 60C with 0.1% SDS,
changing the solution every 10 min, followed by re-hybridizing with a Digoxigenin labeled probe specific for cdc2 (cdc2-SRT
GGGCAGGGTCATAAACAAGC) as described (Cle´ment-Ziza et al., 2014). Quantification of Northern blots has been performed by
ImageJ (Schindelin et al., 2012) as previously described (Rallis et al., 2014). Ratios of each tRNA band signal with the corresponding
cdc2 loading control have been normalized with the ratio at time point 0 for each tRNA and genotype.
QUANTIFICATION AND STATISTICAL ANALYSIS
Northern blot and lifespan AUC quantification has been conducted using ImageJ using 3 independent biological repeats (n = 3).
Significance has been defined using t tests with a p value cutoff of 0.05. Microarray experiments have been conducted in 2 biological
repeats with a dye swap. ChIP-seq experiments have been conducted in 2 biological repeats. Quantifications and statistical analysis
are also described in corresponding STAR Methods sections. Lifespan assays have been performed in three biological repeats with
each time point measured in three technical repeats for each biological replicate. t tests were used for AUC statistics. For Figures S3
and S4, p values refer to adjusted p values using the g:SCS algorithm described in the g:profiler software (Raudvere et al., 2019). For
Figure 1B, each boxplot represents at least 500 measured vacuoles. In Figure S1, each boxplot represents at least 100 measured
cells.
DATA AND CODE AVAILABILITY
Scripts for Analysis
Scripts, packages and programs used for analyses are mentioned in the main text and listed within the Key Resources Table.
Dataset Hosting
The accession numbers for the ChIP-seq data reported in this paper are ENA: PRJEB32910 and ERP115647. The accession number
for the microarray data reported in this paper is ArrayExpress: E-MTAB-8569.Cell Reports 30, 3240–3249.e1–e4, March 10, 2020 e4
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Figure S1. Characterization of Torin1-resistant strains, Related to Figure 1. 
A. Resistance to Torin1 is not a result of multi-drug resistance. Spot assays of wild-type and the 19 resistant
mutants in presence of different drugs as indicated. Control mutants that show multi-drug sensitivity are also
spotted (vam6Δ, gtr1Δ, gtr2Δ) to show that the drugs are functional.
B. Phosphorylation status of ribosomal S6 protein in verified Torin1-resistant mutants in the presence or
absence of Torin1 as indicated.  C. Cell size upon division of wild-type and resistant mutant cells, before (blue)
and after (yellow) Torin1 treatment.
Caffeine Rapamycin Caffeine & RapamycinControl
5 µm 
Figure S2. Fluorescence microscopy of cells expressing GFP-tagged Gaf1, Related to Figure 3.
Cells were grown in YES liquid medium to mid-exponential phase (OD600 =0.5), when caffeine (10 mM), rapamycin 
(100 ng/ml), or both drugs combined at same doses were added, and cells were incubated with shaking at 32°C for 30 
minutes. Control cells were not exposed to the drugs but otherwise treated the same. Cells were photographed in a 
Zeiss Axioskop microscope using the Volocity software. All cells showed nuclear localization of Gaf1 after treatment 
with caffeine or with both drugs; the nuclear translocation of Gaf1 was less efficient in cells treated with rapamycin 
only, reflecting that rapamycin alone only partially inhibits TORC1 in S. pombe (Rallis et al., 2013). 
Figure S3. Functional enrichments among differentially expressed genes, Related to Figure 3. 
Visualization of all GO Biological Process categories enriched among the 108 genes that are repressed (down) 
and the 90 genes that are induced (up). Gene enrichment analysis was done using g:profiler (https://
academic.oup.com/nar/advance-article/doi/10.1093/nar/gkz369/5486750). Results were plotted using a custom R 
script. Colors represent -log10 p values for the GO term enrichments. The size of the bubbles represents the ratio 
between the number of genes in the gene list and the total number of genes in the GO category (in percentage); 
only terms with p values <0.05 are represented. 
Figure S4. Functional enrichments among Gaf1-target genes, Related to Figure 4. 
Visualization of all GO Biological Process categories enriched among the 245 protein-coding genes 
whose promoters are bound by Gaf1 after 60 min of Torin1 treatment. See Figure S3 for details.  
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Figure S5. Gaf1 binding at tRNA genes, Related to Figure 4C. 
Gaf1 binding peaks within Chromosome II region containing clustered tRNA genes (marked in red). Binding 
profiles are shown for cells before (0 min) and 60 min after treatment with Torin 1 as indicated. Signals from 
experimental IPs (GFP) are shown in blue, while control IPs (HA) are shown in grey. 
SYSTEMATIC ID GENE NAME PRODUCT DESCRIPTION
SPAC21E11.04 aca1 L-aze�dine-2-carboxylic acid acetyltransferase Aca1
SPAC17G6.05c bro1 BRO1 domain protein Bro1 (predicted)
SPBC13G1.12 did2 ESCRT III complex subunit Did2 (predicted)
SPAC4F8.01 did4 ESCRT III complex subunit Did4
SPCC1902.01 gaf1 transcrip�on factor Gaf1
SPBC1D7.01 gim6 prefoldin subunit 1 (predicted)
SPBC25B2.04c mtg1 mitochondrial transla�on factor (GTPase) Mtg1 (predicted)
SPBP35G2.11c nbr1 cargo receptor for selec�ve autophagy pathway
SPAC17G6.08 pep7 prevacuole/endosomal FYVE tethering component Pep7 (predicted)
SPAC19B12.10 sst2 human AMSH/STAMBP protein homolog, ubiqui�n speciﬁc-protease
SPBP18G5.03 toc1 Tor complex Tor2 interac�ng protein 1
SPAC11E3.04c ubc13 ubiqui�n conjuga�ng enzyme E2 Ubc13
SPBC215.14c vps20 ESCRT III complex subunit Vps20
SPAC1B3.07c vps28 ESCRT I complex subunit Vps28
SPCC364.05 vps3 CORVET complex subunit, GTPase regulator Vps3 (predicted)
SPAC1142.07c vps32 ESCRT III complex subunit Vps32
SPAC17A2.06c vps8 CORVET complex WD repeat Vps8 (predicted)
SPAC11D3.15 5-oxoprolinase (ATP-hydrolizing) (predicted)
SPBC25B2.03 zf-C3HC4 type zinc ﬁnger
Table S1. Torin1-resistant mutants, Related to Figure 1.
List of the 19 mutants that show resistance to Torin1. Mutants with black fonts have previously been shown to be 
resistant to Torin1. Mutants with red fonts are first reported as Torin1-resistant in this study. 
